Defining distinct features of anti-MOG antibody associated central nervous system demyelination - Martin S. Weber, Tobias Derfuss, Imke Metz, Wolfgang Brück, 2018
MOG antibody demyelination | Great Ormond Street Hospital
Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature - ScienceDirect
Clinical decision making in MOG antibody-associated disease - The Lancet Neurology
Novel MOG assay aids diagnosis of demyelinating diseases - Mayo Clinic
MOG antibody disease: A review of MOG antibody seropositive neuromyelitis optica spectrum disorder - ScienceDirect
IJMS | Free Full-Text | Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Current Insights into the Disease Pathophysiology, Diagnosis and Management
Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated CNS Demyelination: Clinical Spectrum and Comparison with Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder
Frontiers | MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder